Novel therapeutic approach for the treatment of periodontitis by curcumin

Journal of Clinical and Diagnostic Research

Volumn 8, Issue 12, 2014, Pages ZC65-ZC69

  Bhatia, Madhu ^a   Urolagin, Shilpa Sarvesh ^b   Pentyala, Kishore Babu ^a   Urolagin, Sarvesh Basavaraj ^b   Menaka, K B ^c   Bhoi, Shreedevi ^b  

^a New you Cosmetic Clinic   (India)

^b Narsinhbhai Patel Dental College   (India)

^c KLE VK INSTITUTE OF DENTAL SCIENCES   (India)

Author keywords

Curcumin; Local drug delivery; Periodontitis

Indexed keywords

CURCUMIN; CURCUMIN GEL; DISTILLED WATER; POLOXAMER; TOPICAL ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; ARTICLE; BLEEDING INDEX; CAPNOCYTOPHAGA; CHRONIC PERIODONTITIS; CLINICAL ARTICLE; CLINICAL ATTACHMENT LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FUSOBACTERIUM NUCLEATUM; HUMAN; MALE; MEDICAL PARAMETERS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERIODONTAL POCKET; PORPHYROMONAS GINGIVALIS; PREVENTIVE DENTISTRY; PREVOTELLA INTERMEDIA; PROBING POCKET DEPTH; RANDOMIZED CONTROLLED TRIAL; TOOTH PLAQUE;

EID: 84962440864     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2014/8231.5343     Document Type: Article

References (43)

1. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol. 2007; 595:1-75.
2. Sajithal GB, Chithra P, Chandrakasan G. Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. BiochemPharmacol. 1998; 56(12):1607-14.
3. Chainani-Wu N. Safety and anti-infammatory activity of curcumin: a component of tumeric(Curcuma longa). J Altern Complement Med. 2003; 9(1):161-68.
4. Ramsewak RS, Dewitt DL, Nair MG. Cytotoxicity, antioxidant and anti-infammatory activities of curcuminsI-III from Curaima longa. Phytomedicine. 2000;7:303-08.
5. Osawa T, Sugiyama Y, Inayoshi M, Kawakishi S. Antioxidative activity of the tetrahydrocurcuminoids. Biosci Biotechnol Biochem.1995; 59(9):1609-12.
6. Siddiqui AM, Cui X, Wu R, Dong W, Zhou M, Hu M, et al. The anti-infammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Crit Care Med. 2006; 34(7):1874-82.
7. Somparn P, Phisalaphong C, Nakornchai S, Unchern S, Morales NP. Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol Pharm Bull. 2007;30(1):74-78.
8. De R, Kundu P, Swarnakar S, Ramamurthy T, Chowdhury A, Nair GB, et al. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother. 2009;53(4):1592-97.
9. Chan MM, Huang HI, Fenton MR, Fong D. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-infammatory properties. Biochern Pharmacol. 1998;55(12):1955-62.
10. Singh R, Chandra R, Bose M, Luthra PM. Antibacterial activity of curcumin longa rhizome extract on penopathogenic bacteria. Curr Sci. 2002;83:737-40.
11. Pandey A, Gupta RK, Bhargava A, Agrawal B. Antibacterial Activities of Curcumin Bioconjugates.International Journal of Pharmacology.2011; 7(8):874-79.
12. Sidhu GS, Singh AK, Thaloor D, Banaudha KK, Patnaik GK, Srimal RC, et al. Enhancement of wound healing by curcumin in animals. Wound Repair Regen. 1998;6(2):167-77.
13. Manifar S, Obwaller A, Gharehgozloo A, Kordi HR, Akhondzadeh S. Curcumin gel in the treatment of minor aphthous ulcer: A randomized, placebo-controlled trial. Journal of Medicinal Plants.2012;11:40-45.
14. Purushotham Rao K, Vijaybhaskar D, Pratima S. Formulation of topical oral gel for the treatment of oral sub mucous fbrosis (OSI1F). Der Pharmacia Lettre. 2011;3(1):103-12.
15. Waghmare PF, Chaudhari AU, Karhadkar VM, Jamkhande AS. Comparitive evaluation of turmeric and chlorhexidinegluconate mouthwash in prevention of plaque formation and gingivitis: a clinical and microbiological study. J ContempDent Pract. 2011;12(4):221-24.
16. Alvarez AL, Espinar FO, Mendez JB. The application of microencapsulation techniques in the treatment of endodontic and periodontal diseases. Pharmaceutics. 2011;3(3):538-71.
17. Pragati S, Ashok S, Kuldeep S. Recent advances in periodontal drug delivery systems. International Journal of Drug Delivery.2009;1:1-14.
18. Escobar-Chavez JJ, Lopez-Cervantes M, Naik A, Kalia YN, Quintanar-Guerrero D, Ganem-Quintanar A. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci. 2006;9(3):339-58.
19. Bansal K, Rawat MK, Jain A, Rajput A, Chaturvedi TP, Singh S. Development of satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS PharmSciTech. 2009; 10(3):716-23.
20. Smith PC, Santibanez JF, Morales JP, Martinez J. Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fbroblasts. Possible modulation by genistein and curcumin. J Periodontal Res. 2004;39(6):380-87.
21. Guimaraes MR, Coimbra LS, de Aquino SG, Spolidorio LC, Kirkwood KL, Rossa C Jr. Potent anti-infammatory effects of systemically administered curcumin modulate periodontal disease in vivo. J Periodontal Res. 2011;46(2):269-79.
22. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappa β. J Clin Invest. 2001;107(3):241-46.
23. Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventiveagent curcumin involves inhibition of NF-kappaβ activation via the NIK/IKK signalling complex. Oncogene. 1999;18(44):6013-20.
24. Chen H, Zhang ZS, Zhang YL, Zhou DY. Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinomacells. Anticancer Res. 1999;19(5A):3675-80.
25. Zhou H, Beevers CS, Huang S. The targets of curcumin. Curr Drug Targets. 2011;12(3):332-47.
26. Nandini N, Vidya D, Komal A. Comparative evaluation of 1% Curcumin solution and 0.2% Chlorhexidine irrigation as an adjunct to scaling and root planing in management of chronic periodontitis: A clinico-microbiological study. Journal of Pharmaceutical and Biomedical Sciences. 2012;14(3):1-7.
27. Mizrak T, Guncu GN, Caglayan F, Balci TA, Aktar GS, Ipek F. Effect of a controlled-release chlorhexidine chip on clinical and microbiological parameters and prostaglandin E2levels in gingival crevicular fuid. J Periodontol. 2006;77(3):437-43.
28. Soskolne WA, Heasman PA, Stabholz A, Smart GJ, Palmer M, Flashner M, et al. Sustained local delivery of chlorhexidine in the treatment of periodontitis: A multi-center study. J Periodontol. 1997;68(1):32-38.
29. Faveri M, Gursky LC, Feres M, Shibli JA, Salvador SL, de Figueiredo LC. Scaling and root planing and chlorhexidinemouthrinses in the treatment of chronic periodontitis: a randomized, placebo-controlled clinical trial. J Clin Periodontol. 2006;33(11):819-28.
30. Heasman PA, Heasman L, Stacey F, Mccracken GI. Local delivery of chlorhexidine gloconate (periochip) in periodontal maintenance patients. J Clin Periodontol. 2001;28(1):90-95.
31. Azmak N, Atilla G, Luoto H, Sorsa T.The effect of subgingival controlled-release delivery of chlorhexidine chip on clinical parameters and matrix metalloproteinase-8 levels in gingival crevicular fuid. J Periodontol. 2002;73(6):608-15.
32. Lander PE, Newcomb GM, Seymour GJ, Powell RN. The antimicrobial and clinical effects of a single sub-gingival irrigation of chlorhexidine in advanced periodontal lesions. J Clin Periodontol. 1986;13(1):74-80.
33. Quirynen M, Avontroodt P, Peeters W, Pauwels M, Coucke W, van Steenberghe D.Effect of different chlorhexidine formulations in mouthrinses on de novo plaque formation. J Clin Periodontol. 2001;28(12):1127-36.
34. Santos S, Herrera D, Lopez E, O Connor A, Gonzalez I, Sanz M. A randomized clinical trial on the short-term clinical and microbiological effects of the adjunctive use of 0.05% Chlorhexidine mouth rinse for patients in supportive periodontal care. J Clin Periodontol. 2004;31(1):45-51.
35. Suhag A, Dixit J, Dhan P. Role of curcumin as a sub gingival irrigant: A pilot study. J Perio Periodontal Practice Today. 2007;4(2):115-21.
36. Gopinath D, Ahmed MR, Gomathi K, Chitra K, Sehgal PK, Jayakumar R. Dermal wound healing processes with curcumin incorporated collagen flms. Biomaterials. 2004; 25(10):1911-17.
37. Swarnakar S, Ganguly K, Kundu P, Banerjee A, Maity P, Sharma AV. Curcumin regulates expression and activity of matrix metalloproteinases 9and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem. 2005;280(10):9409-15.
38. Newman MG, Takei HH, Klokkevold P, Carranza FA. Micobiology of Periodontal Disease. Clinical Periodontology Edition 10th. Saunders. Philadelphia. 2006:141–43.
39. Kim SJ. Curcumin suppresses the production of interleukin-6 in Prevotellaintermedia lipopolysaccharide-activated RAW 264.7 cells. J Periodontal Implant Sci. 2011;41(3):157-63.
40. Morimoto Y, Kikuchi K, Ito T, Tokuda M, Matsuyama T, Noma S, Hashiguchi T, Torii M, Maruyama I, Kawahara K. MK615 attenuates Porphyromonasgingivalis lipopolysaccharide-induced pro-infammatory cytokine release via MAPK inactivation in murine macrophage-like RAW264.7 cells. Biochem Biophys Res Commun. 2009;389(1):90-94.
41. Banerjee A, Nigam SS.Antimicrobial effcacy of the essential oil of Curcuma longa. Indian J Med Res. 1978;68:864-66.
42. Ungphaiboon S, Supavita T, Singchangchai P, Sungkarak S, Rattanasuwan P, Itharat. A. Study on antioxidant and antimicrobial activities of turmeric clear liquid soap for wound treatment of HIV patients. Songklanakarin J. Sci. Technol.2005;27(2):569-78.
43. Niamsa N, Sittiwet C. Antimicrobial activity of Curcumin Longa aqueous extract. Journal of Pharmacology and Toxicology. 2009;4(4):173-75.